(Q43897259)

27 November 2017

0 references

A case of MAO inhibitor/MDMA interaction: agony after ecstasy (English)

1 reference

27 November 2017

2

Smolinske SC

1 reference

27 November 2017

Smilkstein MJ

1

1 reference

27 November 2017

Rumack BH

series ordinal

3

1 reference

27 November 2017

publication date

1 January 1987

1 reference

Journal of Toxicology: Clinical Toxicology

27 November 2017

published in

1 reference

27 November 2017

volume

25

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

149-159

1 reference

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Severe Hyperpyrexia Due to Tranylcypromine-Amphetamine Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Interactions between sympathomimetic amines and antidepressant agents in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563658708992620

10.3109/15563658708992620

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference